Swisse | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

358 results for “Swisse”

Trials

View all 287 →

Investigating Effects of a Novel Nutraceutical on Hypercholesterolaemia in Australian Adults

42 participants · First posted Mar 5, 2021

The Effects of 12 Weeks Supplementation With a B-vitamin and Herbal Supplement on Neurocognitive Function and Mood

141 participants · First posted Mar 29, 2018

Enrolling By Invitation

Regulation of Lipid Metabolism in Guangzhou Individuals With Dyslipidemia by Red Yeast Rice, Phytosterol Esters and Lycopene

80 participants · First posted May 1, 2023

Drugs

View all 12 →

RSV nAb(Swiss Institute of Bioinformatics)

Monoclonal antibody (Mab) sB24M(SWISS BIOPHARMA)

Mycobacterium ulcerans vaccine (Swiss TPH Institute/Telormedix)

Organizations

View all 21 →

SWISSE WELLNESS PTY LTD

Australia

Bracco Suisse SA

Switzerland

SWISS CAPS AG

Switzerland

News

View all 38 →

Swissmedic and Swissethics Release New Guidelines for Decentralized Clinical Trials

TGA Withdraws Popular Cold and Flu Ingredient From Australian Market

Merck Explores $3+ Billion Acquisition of Swiss Biotech MoonLake Immunotherapeutics

Page 1 of 36